Cortex EP is a United States-based startup aiming to revolutionize the diagnosis and treatment of atrial arrhythmias. The company's slogan, "Cortex aims to transform diagnosis and treatment of AF with insight into each individual’s disease pathophysiology," underlines its core mission. Cortex's OptiMap™ System, a 510k cleared electrographic flow mapping solution infused with AI, empowers physicians to gain valuable insights into each patient's disease pathophysiology, allowing them to See What Matters. The company was established in 2023 and has recently secured a substantial $90.00MPrivate Equity Round investment on 07 December 2023 from leading investors KKR, Hellman & Friedman, and AI Life Sciences Investments.
Cortex EP
Cortex aims to transform diagnosis and treatment of AF with insight into each individual’s disease pathophysiology.
Founded 2023
Santa Clara, United States
27 employees
Private Equity
Total: $90.00M
Santa Clara, United States
27 employees
Private Equity
Total: $90.00M
General Information
Company Name
Cortex EP
Founded Year
2023
Location
Santa Clara, United States
Santa Clara, United States
Employees
27
Funding Stage
Private Equity
BounceWatch is an independent company data service, not affiliated with Cortex EP. To contact Cortex EP, visit CortexEP.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Cortex EP compare?
A PDF of Cortex EP and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Cortex EP soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Cortex EP
Business keywords: AFib, clinical expertise, innovative technology, precision medicine
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Private Equity Round | $90.00M | 3 |
|
07 Dec 2023 |
Cortex EP Alternatives & Competitors
View All Alternatives
Cortex EP vs
bridge7 Oncology
Canada
Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of de...
Seed
4 employees
AI, Health Care
Cortex EP vs
4D Biomaterials
United Kingdom
4Degra® 3D printing biomaterials - helping people heal. Regenerative, resorbable and customisable.
Seed
9 employees
Biotechnology, Health Care
Cortex EP vs
DeepLook Medical
United States
To bring visual intelligence to healthcare providers and confidence to patients
Series A
18 employees
Health Care
FAQ About Cortex EP
Cortex aims to transform diagnosis and treatment of AF with insight into each individual’s disease pathophysiology.
Cortex EP was founded in 2023.
Cortex EP is headquartered in Santa Clara, United States.
Cortex EP has approximately 27 employees.
Cortex EP has completed 1 funding round, raising a total of $90.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Cortex EP include bridge7 Oncology, 4D Biomaterials, DeepLook Medical, Genetika+, Twinical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cortex EP and bridge7 Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Cortex EP, https://bouncewatch.com/company/cortex-ep, updated 20 December 2024. When citing, please name BounceWatch and link this page.
